Francisco Abad‐Santos

6.5k total citations
220 papers, 3.3k citations indexed

About

Francisco Abad‐Santos is a scholar working on Pharmacology, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Francisco Abad‐Santos has authored 220 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pharmacology, 38 papers in Immunology and 36 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Francisco Abad‐Santos's work include Pharmacogenetics and Drug Metabolism (70 papers), Psoriasis: Treatment and Pathogenesis (25 papers) and Drug Transport and Resistance Mechanisms (23 papers). Francisco Abad‐Santos is often cited by papers focused on Pharmacogenetics and Drug Metabolism (70 papers), Psoriasis: Treatment and Pathogenesis (25 papers) and Drug Transport and Resistance Mechanisms (23 papers). Francisco Abad‐Santos collaborates with scholars based in Spain, United States and United Kingdom. Francisco Abad‐Santos's co-authors include Manuel Román, Dolores Ochoa, Teresa Cabaleiro, Miriam Saiz‐Rodríguez, Pablo Zubiaur, Jesús Novalbos, E. Daudén, Dóra Koller, Rocío Prieto‐Pérez and Gina Mejía‐Abril and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Scientific Reports.

In The Last Decade

Francisco Abad‐Santos

203 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Abad‐Santos Spain 31 845 690 527 493 466 220 3.3k
Dolores Ochoa Spain 25 548 0.6× 285 0.4× 207 0.4× 301 0.6× 251 0.5× 98 1.6k
Emanuel Raschi Italy 34 331 0.4× 194 0.3× 636 1.2× 398 0.8× 659 1.4× 169 4.1k
Laura B. Ramsey United States 29 763 0.9× 270 0.4× 604 1.1× 321 0.7× 544 1.2× 105 3.1k
Michael R. Goldberg United States 44 279 0.3× 189 0.3× 1.2k 2.2× 470 1.0× 197 0.4× 192 6.8k
Toshinori Yamamoto Japan 39 824 1.0× 306 0.4× 1.3k 2.4× 118 0.2× 1.1k 2.3× 183 4.2k
Christoph Sachse Germany 22 1.4k 1.7× 145 0.2× 1.1k 2.2× 382 0.8× 861 1.8× 32 3.3k
José A. G. Agúndez Spain 48 2.7k 3.2× 584 0.8× 2.1k 4.0× 478 1.0× 1.3k 2.7× 295 8.4k
Gilberto Castañeda‐Hernández Mexico 31 501 0.6× 401 0.6× 628 1.2× 110 0.2× 229 0.5× 209 3.2k
Oscar Della Pasqua United Kingdom 25 356 0.4× 112 0.2× 504 1.0× 264 0.5× 204 0.4× 159 2.7k
Shufeng Zhou China 34 1.2k 1.5× 392 0.6× 2.3k 4.4× 167 0.3× 913 2.0× 112 5.2k

Countries citing papers authored by Francisco Abad‐Santos

Since Specialization
Citations

This map shows the geographic impact of Francisco Abad‐Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Abad‐Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Abad‐Santos more than expected).

Fields of papers citing papers by Francisco Abad‐Santos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Abad‐Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Abad‐Santos. The network helps show where Francisco Abad‐Santos may publish in the future.

Co-authorship network of co-authors of Francisco Abad‐Santos

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Abad‐Santos. A scholar is included among the top collaborators of Francisco Abad‐Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Abad‐Santos. Francisco Abad‐Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abad‐Santos, Francisco, Salvador F. Aliño, Alberto M. Borobia, et al.. (2024). Developments in pharmacogenetics, pharmacogenomics, and personalized medicine. Pharmacological Research. 200. 107061–107061. 9 indexed citations
3.
Zubiaur, Pablo, et al.. (2024). SLCO1B1 and ABCG2 genotype‐informed phenotypes are related to variation in ramipril exposure. Basic & Clinical Pharmacology & Toxicology. 135(3). 295–307. 1 indexed citations
4.
Ochoa, Dolores, Manuel Román, Gina Mejía‐Abril, et al.. (2024). Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2. International Journal of Molecular Sciences. 26(1). 260–260. 2 indexed citations
5.
Navares‐Gómez, Marcos, Francisca Molina‐Jiménez, Emilio J. Laserna‐Mendieta, et al.. (2024). Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International Journal of Molecular Sciences. 25(7). 3685–3685. 4 indexed citations
6.
Prieto‐Pérez, Rocío, et al.. (2024). Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers. Biomedicines. 13(1). 5–5.
7.
Zubiaur, Pablo, Erin C. Boone, Jean Dinh, et al.. (2023). Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity. Clinical Pharmacology & Therapeutics. 114(5). 1033–1042. 9 indexed citations
8.
Zubiaur, Pablo, Miriam Saiz‐Rodríguez, Marcos Navares‐Gómez, et al.. (2023). Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain. Clinical and Translational Science. 17(1). e13698–e13698.
9.
Saiz‐Rodríguez, Miriam, Dolores Ochoa, Pablo Zubiaur, et al.. (2023). Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of Personalized Medicine. 13(3). 489–489. 9 indexed citations
10.
11.
Villatoro, Jaime Monserrat, Gina Mejía‐Abril, Pablo Zubiaur, et al.. (2022). A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals. 15(1). 78–78. 5 indexed citations
12.
Vázquez, Patricia, Eva Tudurí, Mercedes Mirasierra, et al.. (2021). The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Diabetologia. 65(3). 490–505. 11 indexed citations
13.
Mejía‐Abril, Gina, Pablo Zubiaur, Marcos Navares‐Gómez, et al.. (2021). Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism. Frontiers in Pharmacology. 12. 660639–660639. 5 indexed citations
14.
Llamas‐Velasco, Mar, Alejandra Reolid, Ancor Sanz‐García, et al.. (2020). Methylation in psoriasis. Does sex matter?. Journal of the European Academy of Dermatology and Venereology. 35(2). e161–e163. 3 indexed citations
15.
Cabaleiro, Teresa, Manuel Román, Elena Gallo, et al.. (2013). Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients. European Journal of Dermatology. 23(5). 640–645. 19 indexed citations
16.
Almoguera, Berta, Rosa Riveiro-Álvarez, Jorge López‐Castromán, et al.. (2012). Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population. The Pharmacogenomics Journal. 13(2). 197–204. 20 indexed citations
17.
Abad‐Santos, Francisco, et al.. (2011). Actualización de la eficacia de condroitín sulfato y sulfato de glucosamina en el tratamiento de la artrosis. 9(2). 97–108. 3 indexed citations
18.
Abad‐Santos, Francisco, et al.. (2010). Regulación y evaluación de los ensayos clínicos de terapia celular. Medicina Clínica. 135(1). 35–39. 3 indexed citations
19.
Peiró, Ana M., Jesús Novalbos, Pedro Zapater, et al.. (2008). Pharmacogenetic relevance of the CYP2C93 allele in a tenoxicam bioequivalence study performed on Spaniards. Pharmacological Research. 59(1). 62–68. 11 indexed citations
20.
Abad‐Santos, Francisco, et al.. (2004). Tratamiento de la esclerosis múltiple. 2(1). 19–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dolores Ochoa Breakdown of academic impact, for papers by Emanuel Raschi Breakdown of academic impact, for papers by Laura B. Ramsey Breakdown of academic impact, for papers by Michael R. Goldberg Breakdown of academic impact, for papers by Toshinori Yamamoto Breakdown of academic impact, for papers by Christoph Sachse Breakdown of academic impact, for papers by José A. G. Agúndez Breakdown of academic impact, for papers by Gilberto Castañeda‐Hernández Breakdown of academic impact, for papers by Oscar Della Pasqua Breakdown of academic impact, for papers by Shufeng Zhou
Rankless by CCL
2026